Shasqi Inc. a clinical stage biotech company, has established a scientific advisory board with leaders in oncology (The Cancer Letter, July 28, 2023).
Top FDA officials said the agency is in the process of removing the black box safety warnings from all forms of menopausal hormone therapy, including creams, pills, and other treatments prescribed to ease the symptoms of menopause and perimenopause.
